Dalazatide

ShK-186 · Kineta, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dalazatide, covering 2015-05-18 to 2015-05-18. Get the full timeline:

Most recent: Clinical Trial Update: Multiple Ascending Dose Safety Study of ShK-186 (Dalazatide) in Healthy Volunteers [Phase 1]